The new generation of private polyclinics no longer invests solely in medical equipment. Location, space, technology, and patient experience are increasingly viewed as parts of the same business strategy, and a broader business ecosystem is forming around private healthcare. Part of this community will gather on September 11 in Zagreb for the presentation of the new XERF technology and the American brand Obagi Medical.
Private healthcare in Croatia has undergone a visible transformation in recent years. Polyclinics are expanding, opening new locations, investing in more advanced technologies, and paying increasing attention to the overall patient experience. This also changes the logic of investment itself.
Once, location, space arrangement, medical equipment, and communication with patients could be viewed as separate business decisions. Today, they are increasingly becoming parts of the same strategy.
Patients form their impression of the clinic long before the actual treatment – from location, accessibility, and first contact to space, technology, expertise, and the level of service they receive.
For owners of private polyclinics, this means that investment in growth is no longer just a matter of acquiring another device or opening an additional office. It is about creating a business concept that must simultaneously respond to medical, technological, and market demands.
Technology becomes part of market positioning
The rapid growth of market expectations is also demonstrated by the arrival of new international technologies and brands in Croatia. MedEst will present XERF, a new generation of radiofrequency technology from the global leader in medical aesthetics Cynosure Lutronic, and Obagi Medical, an established American professional skincare brand, on September 11 in Zagreb.
XERF represents the direction in which the device aesthetics market is developing – towards non-invasive technologies that allow treatment of different tissue depths with minimal patient recovery time. The technology combines two frequencies, 6.78 MHz and 2 MHz, enabling doctors to adopt different approaches depending on the indication and treatment area.
XERF has gained global visibility beyond professional circles in medical aesthetics, and the technology is used by numerous world-famous individuals, including Kim Kardashian, Naomi Watts, and Priyanka Chopra Jonas. Their interest further demonstrates how quickly new aesthetic technologies are becoming globally recognized treatments today.
Such development is accompanied by one of the important trends in contemporary medical aesthetics: the growing demand for effective treatments that do not require surgical intervention and long absences from daily life.
Obagi Medical represents the second part of the same transformation. Professional skincare is increasingly associated with procedures performed in polyclinics, creating longer-term care protocols and a relationship with the patient that does not end upon leaving the office.
The American brand has been present in the international professional skincare market for decades, and its arrival in Croatia further expands the range of professional solutions available to doctors and polyclinics.
The arrival of such technologies and brands is important not only for new treatments and products. For private polyclinics, technology and professional skincare are increasingly becoming part of market positioning.
Patients today research, compare devices, products, and treatment approaches, and come to clinics more informed than before. What was once considered a technological advantage is gradually becoming an expected standard.
The polyclinic is no longer just an office
Alongside technological development, the relationship with space is also changing. In the new generation of private polyclinics, space is no longer just a functional backdrop for medical services. Location, accessibility, architecture, privacy, and decor become part of the clinic’s identity and the experience it provides to the patient.
This is particularly pronounced in the premium segment of private healthcare, where healthcare services are increasingly viewed through the lens of the overall experience. For polyclinics entering a phase of expansion, real estate often becomes one of the largest individual investment decisions and a decision that can long-term affect the value and development of the business itself.
Private healthcare has specific requirements. The location must be accessible, the space must allow for adaptation to medical and regulatory requirements, and discretion, parking, room layout, potential for further expansion, and the quality of the micro-location can play an important role. Obagi Medical represents the second part of the same transformation. One of the directions in which professional skincare is developing today is skin longevity – an approach focused not only on correcting visible signs of aging but also on the long-term preservation of skin health, function, and quality. Obagi is developing this direction through a new generation of products such as the NU-GENTM Cellular Renewal Serum, formulated with NAD+, NMN, and niacinamide, aimed at supporting cellular energy and the skin’s natural longevity processes.
At this point, the healthcare and real estate sectors intersect, and the partner for the Zagreb presentation of XERF and Obagi Medical is Eurovilla, one of the most significant companies in the Croatian real estate market, with years of experience in the premium and business segment and advising clients and investors. Real estate is therefore no longer just a business address. It becomes part of the business model and market positioning of the polyclinic.
Choosing real estate for business, especially in specific activities such as private healthcare, is not just a matter of finding the right square footage. Location and micro-location, accessibility and parking, adaptability of space, privacy and representativeness, as well as the potential for future expansion directly affect the quality of business and the long-term value of the investment. These are precisely the questions Eurovilla encounters in working with business clients and investors across Croatia, from finding suitable spaces and locations to advising on real estate investments.
In serious business investments, choosing real estate is not just one of the final steps but an important part of shaping the business concept itself. A good space must respond to the current needs of the business while simultaneously allowing for its future development. In the premium segment, customer experience also joins this – space becomes part of the identity and perception of the brand itself.
The partnership between Eurovilla and MedEst arises precisely from the increasingly strong connection between private healthcare and the real estate sector. The growth and development of clinics increasingly imply serious real estate decisions, from the first office to new polyclinics, additional locations, and larger investment projects.
At the event, doctors, owners, and leading figures of private polyclinics, entrepreneurs, and representatives of companies that operate with this community will meet.
This intersection is particularly interesting as it shows how the growth of private healthcare is developing a significantly broader business ecosystem around it.
The doctor, entrepreneur, and investor are increasingly the same person
Behind the development of private healthcare lies another important change. Doctors who once primarily led medical practices are increasingly managing serious business systems, employing larger teams, making multi-year investment decisions, opening new locations, investing in technology, and building their own brands.
The roles of doctor and entrepreneur are therefore increasingly overlapping. When the owner of a polyclinic decides to expand the business, one decision quickly triggers an entire investment chain.
Where will the new location be? What is the investment in space? What technologies will be part of the offering? How will the space support future growth? What experience does the clinic want to provide to the patient? And finally, how will the entire investment be positioned in an increasingly competitive market?
With this, the number of industries that have a business interest in following the development of the private healthcare sector is also growing – from manufacturers of medical technology and professional skincare companies to the financial, technological, architectural, and real estate sectors. The boundaries between individual investment decisions are becoming less visible.
A new business ecosystem is forming around private healthcare
For this reason, the presentation of XERF and Obagi Medical on September 11 in Zagreb can also be viewed beyond the boundaries of medical aesthetics. International brands, new medical technology, owners of private healthcare businesses, and companies that operate with them in other segments will meet in one place.
Such meetings show that private healthcare is becoming a relevant market for companies that traditionally did not belong to the healthcare industry.
The reason is simple: the growth of private healthcare entails capital investments in real estate, technology, decor, digitalization, employment, marketing, and the development of new services.
The polyclinic is thus no longer just a place for providing healthcare services. It is increasingly becoming a complex business system in which the expertise of doctors must be connected with technology, quality space, an effective business model, and a recognizable patient experience.
A new phase of the market
The next phase of development of Croatian private healthcare will likely not be based solely on a greater number of clinics and new devices. Competition will increasingly revolve around the quality of the entire concept – from expertise and technology to location, space, and patient experience.
For doctors who simultaneously become entrepreneurs and investors, this means more complex business decisions. It is no longer enough to think only about which technology to acquire or how many additional patients the new investment can attract.
The question becomes how to connect individual investments into a system that creates long-term value.
And when technology, capital, space, and experience begin to be viewed as parts of the same investment decision, private healthcare ceases to be interesting only to the healthcare industry and becomes a serious business topic.
